These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Jiang D; Wang R; Xiao B; Kong H; Hunt DJ; Choi P; Zhang L; Chen SR Circ Res; 2005 Nov; 97(11):1173-81. PubMed ID: 16239587 [TBL] [Abstract][Full Text] [Related]
5. Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves. Paavola J; Viitasalo M; Laitinen-Forsblom PJ; Pasternack M; Swan H; Tikkanen I; Toivonen L; Kontula K; Laine M Eur Heart J; 2007 May; 28(9):1135-42. PubMed ID: 17347175 [TBL] [Abstract][Full Text] [Related]
6. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond. Katz G; Arad M; Eldar M Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246 [TBL] [Abstract][Full Text] [Related]
7. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. George CH; Higgs GV; Lai FA Circ Res; 2003 Sep; 93(6):531-40. PubMed ID: 12919952 [TBL] [Abstract][Full Text] [Related]
8. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805 [TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release. Jones PP; Jiang D; Bolstad J; Hunt DJ; Zhang L; Demaurex N; Chen SR Biochem J; 2008 May; 412(1):171-8. PubMed ID: 18092949 [TBL] [Abstract][Full Text] [Related]
11. Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction. George CH; Jundi H; Walters N; Thomas NL; West RR; Lai FA Circ Res; 2006 Jan; 98(1):88-97. PubMed ID: 16339485 [TBL] [Abstract][Full Text] [Related]
12. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling. Kirchhefer U; Wehrmeister D; Postma AV; Pohlentz G; Mormann M; Kucerova D; Müller FU; Schmitz W; Schulze-Bahr E; Wilde AA; Neumann J J Mol Cell Cardiol; 2010 Jul; 49(1):95-105. PubMed ID: 20302875 [TBL] [Abstract][Full Text] [Related]
13. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229 [TBL] [Abstract][Full Text] [Related]
14. Cardiac ryanodine receptor function and regulation in heart disease. Lehnart SE; Wehrens XH; Kushnir A; Marks AR Ann N Y Acad Sci; 2004 May; 1015():144-59. PubMed ID: 15201156 [TBL] [Abstract][Full Text] [Related]
15. Ryanodine receptor-targeted anti-arrhythmic therapy. Wehrens XH; Lehnart SE; Marks AR Ann N Y Acad Sci; 2005 Jun; 1047():366-75. PubMed ID: 16093511 [TBL] [Abstract][Full Text] [Related]
16. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262 [TBL] [Abstract][Full Text] [Related]
17. The CPVT-associated RyR2 mutation G230C enhances store overload-induced Ca2+ release and destabilizes the N-terminal domains. Liu Y; Kimlicka L; Hiess F; Tian X; Wang R; Zhang L; Jones PP; Van Petegem F; Chen SR Biochem J; 2013 Aug; 454(1):123-31. PubMed ID: 23746327 [TBL] [Abstract][Full Text] [Related]
18. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. Song L; Alcalai R; Arad M; Wolf CM; Toka O; Conner DA; Berul CI; Eldar M; Seidman CE; Seidman JG J Clin Invest; 2007 Jul; 117(7):1814-23. PubMed ID: 17607358 [TBL] [Abstract][Full Text] [Related]
19. Role of ryanodine receptor mutations in cardiac pathology: more questions than answers? Thomas NL; George CH; Lai FA Biochem Soc Trans; 2006 Nov; 34(Pt 5):913-8. PubMed ID: 17052226 [TBL] [Abstract][Full Text] [Related]